From: Progress risk assessment of oral premalignant lesions with saliva miRNA analysis
Mean intensity in | Mean intensity in | ||||
---|---|---|---|---|---|
miRNA | Non-progressing LGDs | Progressing LGDs | Fold change | Unadjusted p value | FDR |
miR-10b-5p | 10.2689 | 13.7939 | 11.51↑ | 0.008 | 0.069 |
miR-99a-5p | 10.9423 | 8.1768 | 6.80↓ | 0.011 | 0.069 |
miR-99b-5p | 16.3981 | 12.1692 | 18.75↓ | 0.003 | 0.016 |
miR-145-5p | 13.3692 | 9.6968 | 12.75↓ | 0.011 | 0.069 |
miR-100-5p | 11.9107 | 8.8512 | 8.33↓ | 0.011 | 0.0698 |
miR-125b-5p | 10.9423 | 8.1768 | 6.80↓ | 0.011 | 0.0698 |
miR-181b | 9.9163 | 6.1030 | 14.05↓ | 0.016 | 0.069 |
miR-181c | 20.6273 | 16.6825 | 15.40↓ | 0.011 | 0.069 |
miR-197-3p | 16.4423 | 12.3639 | 16.89↓ | 0.042 | 0.128 |
miR-331-3p | 10.9681 | 8.1938 | 6.84↓ | 0.010 | 0.069 |
miR-15a-5p | 16.5175 | 12.8715 | 12.51↓ | 0.002 | 0.056 |
miR-708 | 8.8610 | 12.4334 | 11.89↑ | 0.014 | 0.069 |
miR-150-5p | 7.9801 | 5.4854 | 5.63↓ | 0.002 | 0.0567 |
miR-30e-3p | 6.6441 | 10.9956 | 20.41↑ | 0.002 | 0.056 |
miR-30a-3p | 15.2221 | 17.1464 | 3.80↑ | 0.049 | 0.985 |
miR-21 | 7.1456 | 9.5243 | 5.20↑ | 0.049 | 0.985 |
let-7a-5p | 20.3130 | 17.7931 | 5.74↓ | 0.039 | 0.985 |
miR-335-5p | 9.2299 | 10.2837 | 2.08↑ | 0.039 | 0.995 |
miR-144* | 11.5283 | 15.1400 | 12.22↑ | 0.005 | 0.057 |
miR-25-3p | 8.8177 | 12.5057 | 12.88↑ | 0 .017 | 0.069 |
miR-19a-3p | 5.3255 | 8.5336 | 9.24↑ | 0.007 | 0.066 |
miR-660-5p | 7.8916 | 12.6950 | 27.92↑ | 0.020 | 0.076 |
miR-140-5p | 11.1943 | 15.2157 | 16.23↑ | 0.012 | 0.069 |
miR-590-5p | 7.4825 | 11.4638 | 15.79↑ | 0.004 | 0.057 |
miR-9 | 21.1533 | 17.9955 | 8.92↓ | 0.039 | 0.915 |